Словаччина - словацька - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ge healthcare b.v., holandsko - fludeoxyglukóza (18f) - 88 - radiopharmaca

Словаччина - словацька - ŠÚKL (Štátny ústav pre kontrolu liečiv)

synektik s.a., , poľsko - fludeoxyglukóza (18f) - 88 - radiopharmaca

Словаччина - словацька - ŠÚKL (Štátny ústav pre kontrolu liečiv)

synektik s.a., , poľsko - fluorid sodný (18f) - 88 - radiopharmaca

Європейський Союз - словацька - EMA (European Medicines Agency)

novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - drogy obštrukčnej choroby dýchacích ciest, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.

Європейський Союз - словацька - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol, mometasone furoate - astma - drogy obštrukčnej choroby dýchacích ciest, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Європейський Союз - словацька - EMA (European Medicines Agency)

novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - drogy obštrukčnej choroby dýchacích ciest, - maintenance treatment of asthma in adults whose disease is not adequately controlled.